Caroline Seymour

Articles

CPX-351 Continues to Improve Survival in Older Patients With AML

July 12, 2021

Data from a 5-year follow-up study confirmed that CPX-351 continues to be associated with long-term remission and improved overall survival compared to 7+3 chemotherapy in certain older patients with acute myeloid leukemia.